Trinity Biotech plc (TRIB)

NASDAQ: TRIB · Real-Time Price · USD

12.43

+0.79 (6.79%)

At close: Aug 7, 2026, 4:00 PM EDT

12.43

0.00 (-0.04%)

After-hours: Aug 7, 2026, 7:34 PM EDT

Trinity Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5.14	5.17	3.69	6.58	25.91
Cash & Short-Term Investments	5.14	5.17	3.69	6.58	25.91
Cash Growth	-0.56%	39.99%	-43.89%	-74.61%	-5.18%
Accounts Receivable	11.48	16.07	13.9	15.75	16.12
Other Receivables	0.46	0.52	1.52	1.83	1.54
Total Trade Receivables	11.94	16.58	15.42	17.59	17.66
Inventory	18.83	19.37	19.93	22.5	29.12
Total Current Assets	35.9	41.12	39.04	46.67	72.69
Net Property, Plant & Equipment	5.3	4.62	1.89	5.68	5.92
Goodwill	56.99	51.34	16.27	35.27	35.98
Long-Term Investments	2.77	2.46	-	-	-
Other Long-Term Assets	4.2	3.75	2.23	4.49	4.31
Total Assets	105.17	103.29	59.44	92.1	118.9

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	29.7	26.78	12.8	15.38	15.13
Current Portion of Long-Term Debt	108.02	-	-	-	-
Current Portion of Leases	2.59	2.29	1.69	1.68	1.98
Other Current Liabilities	0.69	2.82	0.33	0.08	0.07
Total Current Liabilities	141.21	32.1	15.04	17.34	100.49
Long-Term Debt	16.54	88	54.86	58.26	83.31
Long-Term Leases	10.84	10.48	10.87	12.27	13.87
Other Long-Term Liabilities	8.77	8.11	2.83	6.63	4.86
Total Long-Term Liabilities	35.94	106.38	68.35	76.94	18.72
Total Liabilities	177.15	138.47	83.38	94.28	119.21

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.04	4.19	1.97	1.96	1.21
Treasury Stock	-24.92	-24.92	-24.92	-24.92	-24.92
Additional Paid-in Capital	70.51	70.11	53.33	53.17	16.19
Accumulated Other Comprehensive Income	-1.44	-5.44	-5.68	-5.69	-5.36
Retained Earnings	-116.17	-79.12	-48.64	-26.7	12.56
Shareholders' Equity	-71.98	-35.18	-23.95	-2.18	-0.32
Total Liabilities & Equity	105.17	103.29	59.44	92.1	118.9

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	137.98	100.76	67.43	72.2	99.16
Net Cash (Debt)	-132.85	-95.6	-63.74	-65.62	-73.25
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-7.15	-5.32	-8.33	-9.73	-17.52
Book Value	-71.98	-35.18	-23.95	-2.18	-0.32
Book Value Per Share	-3.88	-1.96	-3.13	-0.32	-0.08
Tangible Book Value	-128.97	-86.52	-40.22	-37.45	-36.3
Tangible Book Value Per Share	-6.94	-4.82	-5.25	-5.55	-8.68

SEC Filings: 10-K · 10-Q